阿米卡星及其联合抗生素在7.5%乙醇糊精腹膜透析液中的稳定性与相容性。

IF 2.2 3区 医学 Q3 HEMATOLOGY
Haishan Wu, Pengchao Fang, Zhihao Liu, Haiping Mao, Wei Chen, Xiao Yang, Haiyan Hu, Qunying Guo
{"title":"阿米卡星及其联合抗生素在7.5%乙醇糊精腹膜透析液中的稳定性与相容性。","authors":"Haishan Wu, Pengchao Fang, Zhihao Liu, Haiping Mao, Wei Chen, Xiao Yang, Haiyan Hu, Qunying Guo","doi":"10.1159/000545085","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>The study aimed to evaluate the stability and compatibility of diverse antibiotics in 7.5% icodextrin peritoneal dialysis (PD) solution, subjected to various temperatures over a span of 14-day period.</p><p><strong>Methods: </strong>Antibiotics, namely, amikacin, imipenem, ciprofloxacin, vancomycin, and cefazolin, were incorporated into 7.5% icodextrin solution and subsequently stored at various temperature and period. The concentrations of these antibiotics were measured using high-performance liquid chromatography. Stability of antibiotics is defined as the remaining drug concentration >90% of the initial one throughout the test period.</p><p><strong>Results: </strong>Ciprofloxacin and amikacin were demonstrated stable for a period of 14 days in icodextrin solution across all tested temperatures. Amikacin retained over 90% of its initial concentration when combined with either vancomycin, cefazolin, or ciprofloxacin at various temperatures for 14 days. In combination with amikacin, ciprofloxacin maintained stability for 14 days at all tested temperatures, while vancomycin maintained stability for 14 days at both 4°C and 25°C, and 7 days at 37°C. Cefazolin, however, only exhibited stability for 8 h at 37°C and 7 days at both 4°C and 25°C. The stability of imipenem in icodextrin solution was notably low, remaining stable for a maximum 6 h at 4°C.</p><p><strong>Conclusion: </strong>Ciprofloxacin, amikacin, as well as combinations of amikacin and vancomycin, amikacin and cefazolin, amikacin and ciprofloxacin, can be added to icodextrin solution for treatment of PD-associated peritonitis because they maintain stability for a minimum of 7 days at the temperatures of 4°C and 25°C, and 8 h at 37°C.</p>","PeriodicalId":8953,"journal":{"name":"Blood Purification","volume":" ","pages":"1-9"},"PeriodicalIF":2.2000,"publicationDate":"2025-03-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Stability and Compatibility of Amikacin and Its Combination Antibiotics in 7.5% Icodextrin Peritoneal Dialysis Solution.\",\"authors\":\"Haishan Wu, Pengchao Fang, Zhihao Liu, Haiping Mao, Wei Chen, Xiao Yang, Haiyan Hu, Qunying Guo\",\"doi\":\"10.1159/000545085\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>The study aimed to evaluate the stability and compatibility of diverse antibiotics in 7.5% icodextrin peritoneal dialysis (PD) solution, subjected to various temperatures over a span of 14-day period.</p><p><strong>Methods: </strong>Antibiotics, namely, amikacin, imipenem, ciprofloxacin, vancomycin, and cefazolin, were incorporated into 7.5% icodextrin solution and subsequently stored at various temperature and period. The concentrations of these antibiotics were measured using high-performance liquid chromatography. Stability of antibiotics is defined as the remaining drug concentration >90% of the initial one throughout the test period.</p><p><strong>Results: </strong>Ciprofloxacin and amikacin were demonstrated stable for a period of 14 days in icodextrin solution across all tested temperatures. Amikacin retained over 90% of its initial concentration when combined with either vancomycin, cefazolin, or ciprofloxacin at various temperatures for 14 days. In combination with amikacin, ciprofloxacin maintained stability for 14 days at all tested temperatures, while vancomycin maintained stability for 14 days at both 4°C and 25°C, and 7 days at 37°C. Cefazolin, however, only exhibited stability for 8 h at 37°C and 7 days at both 4°C and 25°C. The stability of imipenem in icodextrin solution was notably low, remaining stable for a maximum 6 h at 4°C.</p><p><strong>Conclusion: </strong>Ciprofloxacin, amikacin, as well as combinations of amikacin and vancomycin, amikacin and cefazolin, amikacin and ciprofloxacin, can be added to icodextrin solution for treatment of PD-associated peritonitis because they maintain stability for a minimum of 7 days at the temperatures of 4°C and 25°C, and 8 h at 37°C.</p>\",\"PeriodicalId\":8953,\"journal\":{\"name\":\"Blood Purification\",\"volume\":\" \",\"pages\":\"1-9\"},\"PeriodicalIF\":2.2000,\"publicationDate\":\"2025-03-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Blood Purification\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000545085\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Blood Purification","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000545085","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

前言:本研究旨在评价各种抗生素在7.5%的icodextrin腹膜透析(PD)溶液中经受不同温度的14天的稳定性和相容性。方法:将抗菌药物阿米卡星、亚胺培南、环丙沙星、万古霉素、头孢唑林加入7.5%的碘糊精溶液中,不同温度、不同贮存时间。采用高效液相色谱法测定抗生素的浓度。抗生素的稳定性定义为整个试验期间剩余药物浓度>为初始浓度的90%。结果:环丙沙星和阿米卡星在icodextrin溶液中在所有测试温度下均稳定14天。当与万古霉素、头孢唑林或环丙沙星在不同温度下联用14天时,阿米卡星仍保持其初始浓度的90%以上。与阿米卡星联用时,环丙沙星在所有温度下均可保持14天的稳定性,万古霉素在4℃和25℃下均可保持14天的稳定性,在37℃下可保持7天的稳定性。然而,头孢唑林在37℃下仅表现出8小时的稳定性,在4℃和25℃下仅表现出7天的稳定性。亚胺培南在icodextrin溶液中的稳定性较低,在4℃下最多能保持6小时的稳定。结论:环丙沙星、阿米卡星,以及阿米卡星与万古霉素、阿米卡星与头孢唑林、阿米卡星与环丙沙星联用治疗腹膜透析相关性腹膜炎,在4℃、25℃温度下至少可保持7天的稳定性,在37℃温度下可保持8小时的稳定性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Stability and Compatibility of Amikacin and Its Combination Antibiotics in 7.5% Icodextrin Peritoneal Dialysis Solution.

Introduction: The study aimed to evaluate the stability and compatibility of diverse antibiotics in 7.5% icodextrin peritoneal dialysis (PD) solution, subjected to various temperatures over a span of 14-day period.

Methods: Antibiotics, namely, amikacin, imipenem, ciprofloxacin, vancomycin, and cefazolin, were incorporated into 7.5% icodextrin solution and subsequently stored at various temperature and period. The concentrations of these antibiotics were measured using high-performance liquid chromatography. Stability of antibiotics is defined as the remaining drug concentration >90% of the initial one throughout the test period.

Results: Ciprofloxacin and amikacin were demonstrated stable for a period of 14 days in icodextrin solution across all tested temperatures. Amikacin retained over 90% of its initial concentration when combined with either vancomycin, cefazolin, or ciprofloxacin at various temperatures for 14 days. In combination with amikacin, ciprofloxacin maintained stability for 14 days at all tested temperatures, while vancomycin maintained stability for 14 days at both 4°C and 25°C, and 7 days at 37°C. Cefazolin, however, only exhibited stability for 8 h at 37°C and 7 days at both 4°C and 25°C. The stability of imipenem in icodextrin solution was notably low, remaining stable for a maximum 6 h at 4°C.

Conclusion: Ciprofloxacin, amikacin, as well as combinations of amikacin and vancomycin, amikacin and cefazolin, amikacin and ciprofloxacin, can be added to icodextrin solution for treatment of PD-associated peritonitis because they maintain stability for a minimum of 7 days at the temperatures of 4°C and 25°C, and 8 h at 37°C.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Blood Purification
Blood Purification 医学-泌尿学与肾脏学
CiteScore
5.80
自引率
3.30%
发文量
69
审稿时长
6-12 weeks
期刊介绍: Practical information on hemodialysis, hemofiltration, peritoneal dialysis and apheresis is featured in this journal. Recognizing the critical importance of equipment and procedures, particular emphasis has been placed on reports, drawn from a wide range of fields, describing technical advances and improvements in methodology. Papers reflect the search for cost-effective solutions which increase not only patient survival but also patient comfort and disease improvement through prevention or correction of undesirable effects. Advances in vascular access and blood anticoagulation, problems associated with exposure of blood to foreign surfaces and acute-care nephrology, including continuous therapies, also receive attention. Nephrologists, internists, intensivists and hospital staff involved in dialysis, apheresis and immunoadsorption for acute and chronic solid organ failure will find this journal useful and informative. ''Blood Purification'' also serves as a platform for multidisciplinary experiences involving nephrologists, cardiologists and critical care physicians in order to expand the level of interaction between different disciplines and specialities.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信